PATRICIA HAGERMAN: Open Payments
NPI 1346216249 · LAWRENCEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$444 in 23 payments from 14 companies in 2025. Trend: 2023 $271 · 2024 $665 · 2025 $444
Food & beverage: $444
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $75 |
| Lilly USA, LLC | 3 | $63 |
| Novo Nordisk Inc | 3 | $56 |
| Abbott Laboratories | 2 | $41 |
| Exact Sciences Corporation | 2 | $34 |
| Astellas Pharma US Inc | 1 | $26 |
| SHIELD THERAPEUTICS INC | 1 | $23 |
| Dynavax Technologies Corporation | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| PFIZER INC. | 1 | $18 |
Products named: MOUNJARO, FARXIGA, AIRSUPRA, Cologuard Collection Kit, Ozempic, Veozah, ETERNA, ACCRUFER.
Industry payments across GA — which companies pay providers there.
